相似文献
1
COVID-19 infection in febrile neutropenic pediatric hematology oncology patients.发热性中性粒细胞减少的儿科血液肿瘤患者中的新型冠状病毒肺炎感染
Pediatr Blood Cancer. 2021 Feb;68(2):e28765. doi: 10.1002/pbc.28765. Epub 2020 Oct 16.
2
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.描述儿科肿瘤患者的 COVID-19 疾病特征：纽约-新泽西地区的经验。
Pediatr Blood Cancer. 2021 Mar;68(3):e28843. doi: 10.1002/pbc.28843. Epub 2020 Dec 18.
3
COVID-19 in pediatric cancer patients in a resource-limited setting: National data from Peru.资源有限环境下儿科癌症患者中的新冠病毒病：来自秘鲁的全国数据。
Pediatr Blood Cancer. 2021 Feb;68(2):e28610. doi: 10.1002/pbc.28610. Epub 2020 Jul 22.
4
Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19.新型冠状病毒肺炎患儿的血液学参数及外周血形态学异常
Pediatr Blood Cancer. 2021 Feb;68(2):e28596. doi: 10.1002/pbc.28596. Epub 2020 Aug 6.
5
COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients.COVID-19 血清流行率及瑞典儿科肿瘤和血液学患者的临床表现。
Pediatr Blood Cancer. 2022 Oct;69(10):e29773. doi: 10.1002/pbc.29773. Epub 2022 May 25.
6
COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.COVID-19 与儿科癌症患者的治疗中断有关，但与短期死亡率无关：一项波兰全国性研究。
J Hematol Oncol. 2021 Oct 11;14(1):163. doi: 10.1186/s13045-021-01181-4.
7
Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.降钙素原和C反应蛋白在鉴别儿童发热性中性粒细胞减少症病情稳定与恶化临床病程中的作用。
J Pediatr Hematol Oncol. 2007 Feb;29(2):107-11. doi: 10.1097/MPH.0b013e3180320b5b.
8
Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China.《中国某单一中心 78 例 COVID-19 肺炎患者合并常见呼吸道病原体感染及实验室生物化学检查结果的回顾性横断面研究》
Med Sci Monit. 2021 Jan 3;27:e929783. doi: 10.12659/MSM.929783.
9
A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.一项关于 SARS-CoV-2 患者的荟萃分析确定了 D-二聚体、C 反应蛋白、淋巴细胞和中性粒细胞值的组合意义，作为疾病严重程度的预测指标。
Int J Lab Hematol. 2021 Apr;43(2):324-328. doi: 10.1111/ijlh.13354. Epub 2020 Oct 3.
10
Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt.COVID-19 大流行期间住院的 1 型糖尿病儿童和青少年患者的临床特征和结局：来自埃及单中心监测研究的数据。
J Pediatr Endocrinol Metab. 2021 Apr 22;34(7):925-936. doi: 10.1515/jpem-2021-0099. Print 2021 Jul 27.
引用本文的文献
1
COVID-19 infection in children with blood cancer: A systematic review.血癌患儿的新冠病毒感染：一项系统综述
Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5.
2
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.中东人群中 COVID-19 的预后：已知与未知
Front Microbiol. 2022 Aug 31;13:974205. doi: 10.3389/fmicb.2022.974205. eCollection 2022.
3
COVID-19 in Children with Cancer.儿童癌症患者中的 COVID-19 。
Curr Oncol Rep. 2022 Mar;24(3):295-302. doi: 10.1007/s11912-022-01207-1. Epub 2022 Feb 3.
4
COVID-19 in Children and Adolescents: Characteristics and Specificities in Immunocompetent and Oncohematological Patients.儿童和青少年中的COVID-19：免疫功能正常和肿瘤血液学患者的特征及特异性
Mediterr J Hematol Infect Dis. 2022 Jan 1;14(1):e2022009. doi: 10.4084/MJHID.2022.009. eCollection 2022.
5
COVID-19 infection in pediatric patients treated for cancer.COVID-19 感染在接受癌症治疗的儿科患者中。
Int J Clin Oncol. 2022 Feb;27(2):448-454. doi: 10.1007/s10147-021-02068-7. Epub 2021 Nov 6.
6
Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country.管理和结局的 2019 年冠状病毒病（COVID-19）在儿科癌症患者：单一中心的经验从一个发展中国家。
Clin Lymphoma Myeloma Leuk. 2021 Nov;21(11):e853-e864. doi: 10.1016/j.clml.2021.07.025. Epub 2021 Jul 26.
7
Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.儿童癌症与 COVID-19 患者的临床表现和结局：一项系统综述。
Pediatr Blood Cancer. 2021 Jun;68(6):e29005. doi: 10.1002/pbc.29005. Epub 2021 Mar 15.
8
Impacts of COVID-19 on caregivers of childhood cancer survivors.COVID-19 对儿童癌症幸存者照顾者的影响。
Pediatr Blood Cancer. 2021 Apr;68(4):e28943. doi: 10.1002/pbc.28943. Epub 2021 Feb 9.
本文引用的文献
1
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.新型冠状病毒肺炎与肺癌：风险、机制和治疗相互作用。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000892.
2
COVID-19 in Children With Cancer in New York City.纽约市癌症儿童中的 COVID-19 。
JAMA Oncol. 2020 Sep 1;6(9):1459-1460. doi: 10.1001/jamaoncol.2020.2028.
3
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
4
SARS-CoV-2 Infection in Children.儿童感染新型冠状病毒2型
N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis.铁螯合疗法对低/中危国际预后评分系统（IPSS）骨髓增生异常综合征（MDS）患者的影响及血清铁蛋白升高在MDS和急性髓系白血病（AML）患者中的预后作用：一项荟萃分析。
Medicine (Baltimore). 2019 Oct;98(40):e17406. doi: 10.1097/MD.0000000000017406.
Zotero 插件